Artemis Medicare Services Limited

rs,

Complex, Bandra (E), Mumbai – 400 051 Listing Department, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 NSE Symbol: ARTEMISMED Scrip Code: 542919 Sub: Earning Present

INR 26,

Highlights (Gurgaon) Q4 FY 26 & FY 26 Y o Y 4 Q Y o Y 6 2 Y F Revenue from Operations Q4 FY 26 INR 26, 746 Lacs 18.8% Q4 FY 25 INR 22,520 Lacs Revenue from Operations FY 26 INR 1,03,022 Lacs 17.8%

18.8%

n) Q4 FY 26 & FY 26 Y o Y 4 Q Y o Y 6 2 Y F Revenue from Operations Q4 FY 26 INR 26, 746 Lacs 18.8% Q4 FY 25 INR 22,520 Lacs Revenue from Operations FY 26 INR 1,03,022 Lacs 17.8% FY 25 INR 87,

INR 22,520

Y 26 Y o Y 4 Q Y o Y 6 2 Y F Revenue from Operations Q4 FY 26 INR 26, 746 Lacs 18.8% Q4 FY 25 INR 22,520 Lacs Revenue from Operations FY 26 INR 1,03,022 Lacs 17.8% FY 25 INR 87,424 Lacs EBITDA Q4 F

INR 1,03,022

ations Q4 FY 26 INR 26, 746 Lacs 18.8% Q4 FY 25 INR 22,520 Lacs Revenue from Operations FY 26 INR 1,03,022 Lacs 17.8% FY 25 INR 87,424 Lacs EBITDA Q4 FY 26 INR 5,804 Lacs 20.6% Q4 FY 25 INR 4,814 Lacs

17.8%

R 26, 746 Lacs 18.8% Q4 FY 25 INR 22,520 Lacs Revenue from Operations FY 26 INR 1,03,022 Lacs 17.8% FY 25 INR 87,424 Lacs EBITDA Q4 FY 26 INR 5,804 Lacs 20.6% Q4 FY 25 INR 4,814 Lacs IP Volume

INR 87,424

18.8% Q4 FY 25 INR 22,520 Lacs Revenue from Operations FY 26 INR 1,03,022 Lacs 17.8% FY 25 INR 87,424 Lacs EBITDA Q4 FY 26 INR 5,804 Lacs 20.6% Q4 FY 25 INR 4,814 Lacs IP Volume Q4 FY 26 8,712

INR 5,804

Revenue from Operations FY 26 INR 1,03,022 Lacs 17.8% FY 25 INR 87,424 Lacs EBITDA Q4 FY 26 INR 5,804 Lacs 20.6% Q4 FY 25 INR 4,814 Lacs IP Volume Q4 FY 26 8,712 9.2% Q4 FY 25 7,979 ARPP Q4

20.6%

erations FY 26 INR 1,03,022 Lacs 17.8% FY 25 INR 87,424 Lacs EBITDA Q4 FY 26 INR 5,804 Lacs 20.6% Q4 FY 25 INR 4,814 Lacs IP Volume Q4 FY 26 8,712 9.2% Q4 FY 25 7,979 ARPP Q4 FY 26 INR 3

INR 4,814

INR 1,03,022 Lacs 17.8% FY 25 INR 87,424 Lacs EBITDA Q4 FY 26 INR 5,804 Lacs 20.6% Q4 FY 25 INR 4,814 Lacs IP Volume Q4 FY 26 8,712 9.2% Q4 FY 25 7,979 ARPP Q4 FY 26 INR 3,06,993 8.8% Q4 FY

9.2%

Lacs EBITDA Q4 FY 26 INR 5,804 Lacs 20.6% Q4 FY 25 INR 4,814 Lacs IP Volume Q4 FY 26 8,712 9.2% Q4 FY 25 7,979 ARPP Q4 FY 26 INR 3,06,993 8.8% Q4 FY 25 INR 2,82,229 EBITDA IP Volume ARP

INR 3,06,993

20.6% Q4 FY 25 INR 4,814 Lacs IP Volume Q4 FY 26 8,712 9.2% Q4 FY 25 7,979 ARPP Q4 FY 26 INR 3,06,993 8.8% Q4 FY 25 INR 2,82,229 EBITDA IP Volume ARPP FY 26 INR 21,785 Lacs 17.2% FY 25 INR 18,5

“• PAT of INR 104 Cr in FY26 against INR 82 Cr in FY 25, growth of 26.2% • Consolidated Diluted EPS for Q4 FY26 of INR 1.90, growth of 31.0% on YoY basis.”

“• Consolidated Diluted EPS for FY26 of INR 6.56, growth of 23.5% on YoY basis.”

Note

4

Note

* Other income declined due to utilisation of IFC funds towards expansion projects ** One-time exceptional item of INR 3.07 Cr adjusted on account of Gratuity and Leave -encashm ent provision in Q3 FY 26 R: 191 G: 176 B: 65 R: 255 G: 196 B: 63 R: 170 G: 127 B: 0 R: 245 G: 206 B: 70 R: 158 G: 139 B: 56 R: 235 G: 177 B: 0 R: 189 G: 142 B: 0 R: 155 G: 152 B: 109 R: 237 G: 125 B: 49 Financial Highlights Q4 FY26 Consolidated FY26 Consolidated • Revenue from Operations of INR 279 Cr, growth of 16.4% on YoY basis • Revenue from Operations of INR 1,081 Cr, growth of 15.4% on YoY basis • EBITDA of INR 59 Cr, growth of 23.1% on YoY basis. • EBITDA of INR 218 Cr, growth of 18.0% on YoY basis. • EBITDA margin of 21.3% vs. 20.1% in Q4 FY25. • EBITDA margin of 20.2% vs. 19.7% in FY25. • PAT of INR 30 Cr in Q4 FY 26, growth of 32.1% on YoY basis. • PAT of INR 104 Cr in FY26 against INR 82 Cr in FY 25, growth of 26.2% • Consolidated Diluted EPS for Q4 FY26 of INR 1.90, growth of 31.0% on YoY basis. •

Note

* Other income declined due to utilisation of IFC funds towards expansion projects ** One-time exceptional item of INR 3.07 Cr adjusted on account of Gratuity and Leave -encashme nt provision in Q3 FY26 R: 191 G: 176 B: 65 R: 255 G: 196 B: 63 R: 170 G: 127 B: 0 R: 245 G: 206 B: 70 R: 158 G: 139 B: 56 R: 235 G: 177 B: 0 R: 189 G: 142 B: 0 R: 155 G: 152 B: 109 R: 237 G: 125 B: 49 Welcome to the World of Artemis Artemis Hospitals is a healthcare venture launched by the promoters of the Apollo Tyres Group. Our portfolio includes a 700 bed super speciality hospital in Gurugram (Delhi-NCR), India and further expanding to ~2,000 beds by 2028. Top of the line Advanced Technology State-of-the-Art Tertiary Care Hospital 14 40+ Centres of Excellence Medical Specialities 500+ Doctors 1st JCI Accredited Hospital in Gurgaon 100+ Business Tie-ups with Corporates 100+ Countries Patients R: 191 G: 176 B: 65 R: 255 G: 196 B: 63 R: 170 G: 127 B: 0 R: 245 G: 206 B: 70 R: 158 G: 139 B: 56 R: 235 G: 177 B:

Note

768 1,223 28,146 24,703 16,019 4,396 1,934 5,797 21.2% 1,238 4,558 16.6% 631 - 3,928 973 2,955 10.8% 14,298 3,800 1,828 4,777 20.3% 1,125 3,653 15.6% 753 - 2,900 579 2,320 9.9% YoY% 16.6% -37.3% 13.9% 12.0% 15.7% 5.8% 21.3% 10.1% 24.8% -16.2% 35.4% 68.0% 27.3% R: 191 G: 176 B: 65 R: 255 G: 196 B: 63 R: 170 G: 127 B: 0 R: 245 G: 206 B: 70 R: 158 G: 139 B: 56 R: 235 G: 177 B: 0 R: 189 G: 142 B: 0 R: 155 G: 152 B: 109 R: 237 G: 125 B: 49 Q3 FY26 QoQ% FY26 26,712 749 27,461 16,342 4,231 1,759 5,129 19.2% 1,205 3,924 14.7% 659 307 2,957 706 2,251 8.4% 2.5% 2.5% 2.5% -2.0% 3.9% 9.9% 13.0% 2.8% 16.2% -4.4% 32.8% 37.8% 31.2% 106,049 2,990 FY25 91,326 3,292 109,040 94,618 64,091 16,184 7,261 21,503 20.3% 4,633 55,161 14,371 6,811 18,276 20.0% 4,302 16,870 13,974 15.9% 2,694 307 13,868 3,524 10,344 9.8% 15.3% 3,048 - 10,925 2,580 8,346 9.1% YoY% 16.1% -9.1% 15.2% 16.2% 12.6% 6.6% 17.7% 7.7% 20.7% -11.6% 26.9% 36.6% 23.9% *Other income declined due to utilisation of IFC funds towards expansion pr

Note

779 28,701 16,277 4,497 1,989 5,938 21.3% 1,276 4,663 16.7% 637 - 4,025 997 3,028 10.8% 1,235 25,225 14,591 3,914 1,895 4,824 20.1% 1,174 3,650 15.2% 783 - 2,866 574 2,292 9.6% R: 191 G: 176 B: 65 R: 255 G: 196 B: 63 R: 170 G: 127 B: 0 R: 245 G: 206 B: 70 R: 158 G: 139 B: 56 R: 235 G: 177 B: 0 R: 189 G: 142 B: 0 R: 155 G: 152 B: 109 R: 237 G: 125 B: 49 YoY% 16.4% -36.9% 13.8% 11.6% 14.9% 5.0% 23.1% 8.6% 27.8% -18.6% 40.4% 73.7% 32.1% Q3 FY26 QoQ% 27,235 746 27,981 16,612 4,342 1,824 5,203 19.1% 1,244 3,959 14.5% 675 307 2,977 753 2,223 8.2% 2.5% 4.4% 2.6% -2.0% 3.6% 9.0% 14.1% 2.5% 17.8% -5.5% 35.2% 32.4% 36.2% FY26 108,124 2,983 111,107 65,162 16,607 7,538 21,801 20.2% 4,807 16,994 15.7% 2,769 307 13,918 3,546 10,372 9.6% FY25 93,692 3,299 96,990 56,522 14,837 7,154 YoY% 15.4% -9.6% 14.6% 15.3% 11.9% 5.4% 18,478 18.0% 19.7% 4,516 13,961 14.9% 3,194 - 10,767 2,549 8,218 8.8% 6.4% 21.7% -13.3% 29.3% 39.1% 26.2% • Other income declined due to utilisation of IFC funds towards expansion pr